Sentiment-Signal
Score-Verlauf (90 Tage)
Stammdaten
Caris Life Sciences, Inc., an artificial intelligence TechBio company, provides molecular profiling services in the United States and internationally. It develops and commercializes solutions to transform healthcare using molecular information, and machine learning algorithms. The company's molecular profiling services portfolio includes MI Profile, a tissue-based molecular profiling solution; and Caris Assure, a blood-based molecular profiling solution for cancer treatment. It also offers pharma research and development services comprising laboratory delivery, strategic data, and research services to biopharmaceutical customers. The company was founded in 2008 and is headquartered in Irving, Texas.
Unternehmen & Branche
| Name | Caris Life Sciences, Inc. |
|---|---|
| Ticker | CAI |
| CIK | 0002019410 |
| Boerse | US |
| Sektor | Healthcare |
| Industrie | Biotechnology |
| SIC | 8071 · Services-Medical Laboratories |
Wertpapier & Kennzahlen
| CUSIP | – |
|---|---|
| ISIN | – |
| Typ | Common Stock |
| Marktkapitalisierung | 4,98 Mrd. USD |
| Beta | 1,33 |
| Dividendenrendite | 0,00 % |
Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2025-12-31 | 10-K | 812,033,000 | -68,088,000 | -3.22 | 1,125,663,000 | 577,307,000 |
| 2025-09-30 | 10-Q | 216,833,000 | 24,325,000 | 0.08 | 984,571,000 | 478,364,000 |
| 2025-06-30 | 10-Q | 181,398,000 | -71,790,000 | -7.97 | 955,058,000 | 452,904,000 |
| 2024-12-31 | 10-K | 412,260,000 | -281,890,000 | -10.66 | 343,734,000 | -2,498,838,000 |
| 2024-09-30 | 10-Q | 101,620,000 | -67,729,000 | -2.59 | -2,441,953,000 | |
| 2024-06-30 | 10-Q | 100,049,000 | -66,186,000 | -2.54 | -2,359,590,000 | |
| 2023-12-31 | 10-K | 306,128,000 | -341,415,000 | -13.24 | -2,144,950,000 |
Fondsaktivität (Vorquartalsvergleich)
Insider-Transaktionen (12 Monate)
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2025-12-11 | Power Luke Thomas | Officer, See Remarks | Open Market Sale | -1,400 | 27.16 | -38,017.56 | -8,9% | |
| 2025-12-11 | Power Luke Thomas | Officer, See Remarks | Open Market Sale | -60,850 | 26.56 | -1,616,443.74 | -380,0% | |
| 2025-11-07 | Denton John Russel | Officer, See Remarks | Open Market Purchase | 4,184 | 24.09 | 100,792.56 | +23,7% | |
| 2025-11-07 | Spetzler David Baxley | Officer, President | Open Market Purchase | 400 | 23.85 | 9,540.00 | +2,2% | |
| 2025-06-20 | Denton John Russel | Officer, See Remarks | Open Market Purchase | 7,500 | 21.00 | 157,500.00 | +37,0% | |
| 2025-06-20 | Brille Brian J | Director, Officer, See Remarks | Open Market Purchase | 30,000 | 21.00 | 630,000.00 | +148,1% |
Top-Fondshalter
Keine Fondsdaten zu dieser Aktie vorhanden.